Haddad M, Triglia J M, Helardot P, Couanet D, Gauthier F, Neuenschwander S, Bourlière B, Bergeron C, Munzer C, Rubie H, Guys J M
Pediatric Surgery Department, Hôpital d'Enfants de la Timone, 264 rue Saint Pierre, 13385 Marseille 5, France.
Int J Pediatr Otorhinolaryngol. 2003 Dec;67(12):1361-7. doi: 10.1016/j.ijporl.2003.08.046.
The purpose of this study focused on cervical neuroblastoma (NB) was to assess the prognosis, define the most suitable methods of investigation, and evaluate risk factors for complications following primary surgery.
Between 1990 and 1999, we conducted two consecutive prospective multicentric studies (NBL90 and NBL94) on localized NB. Because the first study (1990-1994) found surgery-related morbidity and mortality, several surgical risk factors (i.e. adhesion to major vessels, size, friability, and dumb bell tumor) were defined and used prospectively as criteria of resectability in the second study (1994-1999).
Of 617 cases included in the two studies, 43 involved cervical NB including 17 cervicothoracic tumors. With a median follow-up of 4 years, overall survival and event-free survival rates were 91 and 81%, respectively with no significant difference between cervical or cervicothoracic NB. Seventeen patients were included in the second study; surgery was used as the first line treatment in 11. Full pre-operative work-up was performed in eight patients, demonstrating one or more risk factors in three. The remaining three patients underwent emergency surgery with no pre-operative work-up or only ultrasound: two developed serious complications. All three patients presenting documented risk factors developed post-operative complications versus only two of the eight patients who presented no risk factor (n = 5) or were inadequately evaluated (n = 3) (P = 0.06). None of the five patients in whom full work-up demonstrated no risk factor had post-operative complications (P = 0.02).
Cervical neuroblastoma has a favorable prognosis. Surgery is the treatment of choice but there is a risk of complications. Appropriate pre-operative work-up is mandatory to evaluate resectability. The surgical risk factors defined for our second study seem to be significant predictors of post-operative complications.
本研究聚焦于颈部神经母细胞瘤(NB),旨在评估其预后,确定最合适的检查方法,并评估初次手术后并发症的危险因素。
1990年至1999年间,我们针对局限性NB进行了两项连续的前瞻性多中心研究(NBL90和NBL94)。由于第一项研究(1990 - 1994年)发现了与手术相关的发病率和死亡率,因此确定了几个手术危险因素(即与大血管粘连、大小、易碎性和哑铃形肿瘤),并在第二项研究(1994 - 1999年)中前瞻性地用作可切除性的标准。
两项研究共纳入617例病例,其中43例为颈部NB,包括17例颈胸段肿瘤。中位随访4年,总体生存率和无事件生存率分别为91%和81%,颈部或颈胸段NB之间无显著差异。17例患者纳入第二项研究;11例患者将手术作为一线治疗。8例患者进行了全面的术前检查,其中3例显示有一个或多个危险因素。其余3例患者未进行术前检查或仅进行了超声检查就接受了急诊手术:2例出现严重并发症。所有3例有记录的危险因素患者均发生了术后并发症,而8例无危险因素(n = 5)或评估不充分(n = 3)的患者中只有2例发生术后并发症(P = 0.06)。5例全面检查未显示危险因素患者均未发生术后并发症(P = 0.02)。
颈部神经母细胞瘤预后良好。手术是首选治疗方法,但存在并发症风险。必须进行适当的术前检查以评估可切除性。我们第二项研究中确定的手术危险因素似乎是术后并发症的重要预测指标。